Latest News

Foghorn Therapeutics Provides Update on FHD-909 and Strategic Priorities

Origin Agritech Strengthens Liquidity by Selling Its Xinjiang Seed Subsidiary and Leasing Back the Production Base

What Are the 5 Signs of Poor Metabolic Health Adults May Overlook?

Ocular Therapeutix™ to Participate in October Scientific and Investor Conferences

Monte Rosa Therapeutics Announces Positive Results for MRT-8102 in GFORCE-1 Phase 1 Study Showing Normalization of Key Pathogenic Drivers of ASCVD in Subjects with Elevated CVD Risk

NHI Announces $107.7 Million SHOP Investment

Ecopetrol Group, in coordination with the National Government, receives payment of the Fuel Price Stabilization Fund (FEPC, by its Spanish acronym) receivable corresponding to the third and fourth quarters of 2025

GDEV Management-backed Relevate Power and Eagle Creek Form Strategic Partnership to Expand Companies' Hydropower Footprints

Lilly's oral GLP-1, Foundayo (orforglipron), was associated with significant reductions in predicted long-term risk of type 2 diabetes and cardiovascular disease

Keurig Dr Pepper Names Russ Torres Chief Executive Officer of Future Global Coffee Co.